Loading…

Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020

To perform a meta-analysis of case-control studies that addressed the association between oral contraceptive pills (OC) use and breast cancer (BrCa), PubMED (MEDLINE), Embase, and the Cochrane Library were searched to identify case-control studies of OC and BrCa published between 2009 and 2020. We u...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2021-11, Vol.13 (22), p.5654
Main Authors: Barańska, Agnieszka, Błaszczuk, Agata, Kanadys, Wiesław, Malm, Maria, Drop, Katarzyna, Polz-Dacewicz, Małgorzata
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023
cites cdi_FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023
container_end_page
container_issue 22
container_start_page 5654
container_title Cancers
container_volume 13
creator Barańska, Agnieszka
Błaszczuk, Agata
Kanadys, Wiesław
Malm, Maria
Drop, Katarzyna
Polz-Dacewicz, Małgorzata
description To perform a meta-analysis of case-control studies that addressed the association between oral contraceptive pills (OC) use and breast cancer (BrCa), PubMED (MEDLINE), Embase, and the Cochrane Library were searched to identify case-control studies of OC and BrCa published between 2009 and 2020. We used the DerSimonian–Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs), and the Mantel–Haenszel test to assess the association between OC use and cancer. Forty-two studies were identified that met the inclusion criteria and we included a total of 110,580 women (30,778 into the BrCa group and 79,802 into the control group, of which 15,722 and 38,334 were using OC, respectively). The conducted meta-analysis showed that the use of OC was associated with a significantly increased risk of BrCa in general, OR = 1.15, 95% CI: 1.01 to 1.31, p = 0.0358. Regarding other risk factors for BrCa, we found that increased risk was associated significantly with early menarche, nulliparous, non-breastfeeding, older age at first parity, postmenopause, obesity, smoking, and family history of BrCa. Despite our conclusion that birth control pills increase the cancer risk being supported by extensive previous studies and meta-analyzes, further confirmation is required.
doi_str_mv 10.3390/cancers13225654
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8616467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2604028463</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023</originalsourceid><addsrcrecordid>eNpdkUtP3DAQx62qVUGUc6-WeuHQFMfO2gmHSsuKPiQQEo-z5Tjj1pDEW4-zaG899Bv0G_aT1LsgBPgy1sxv_vMi5H3JPgnRsENrRgsRS8H5TM6qV2SXM8ULKZvq9ZP_DtlHvGH5CVEqqd6SHVHVgtVM7ZI_59H0dBHGFI2FZfIroNcI1IwdPY5gMNHFtgy98HhL54iAOMCYjuicXq4xwWCSt_QCVh7utmlnkEwxH02_Ro80uCyAUGxLhJ5epqnzgB8pZ6z59_svZ5y9I2-c6RH2H-weuf5ycrX4Vpyef_2-mJ8WVjR1KloQXQduVsqc40DmISrB69o5xoWyHFgDrXHgmlZZ2UrHq5rzLvukmTWZ2SOf73WXUztAZ2Ezda-X0Q8mrnUwXj-PjP6n_hFWupalrKTKAgcPAjH8mgCTHjxa6HszQphQc8kqxutKiox-eIHehCnmrWwpzkqlyk1Hh_eUjQExgntspmR6c2T94sjiP9WHmuQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2602017712</pqid></control><display><type>article</type><title>Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Barańska, Agnieszka ; Błaszczuk, Agata ; Kanadys, Wiesław ; Malm, Maria ; Drop, Katarzyna ; Polz-Dacewicz, Małgorzata</creator><creatorcontrib>Barańska, Agnieszka ; Błaszczuk, Agata ; Kanadys, Wiesław ; Malm, Maria ; Drop, Katarzyna ; Polz-Dacewicz, Małgorzata</creatorcontrib><description>To perform a meta-analysis of case-control studies that addressed the association between oral contraceptive pills (OC) use and breast cancer (BrCa), PubMED (MEDLINE), Embase, and the Cochrane Library were searched to identify case-control studies of OC and BrCa published between 2009 and 2020. We used the DerSimonian–Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs), and the Mantel–Haenszel test to assess the association between OC use and cancer. Forty-two studies were identified that met the inclusion criteria and we included a total of 110,580 women (30,778 into the BrCa group and 79,802 into the control group, of which 15,722 and 38,334 were using OC, respectively). The conducted meta-analysis showed that the use of OC was associated with a significantly increased risk of BrCa in general, OR = 1.15, 95% CI: 1.01 to 1.31, p = 0.0358. Regarding other risk factors for BrCa, we found that increased risk was associated significantly with early menarche, nulliparous, non-breastfeeding, older age at first parity, postmenopause, obesity, smoking, and family history of BrCa. Despite our conclusion that birth control pills increase the cancer risk being supported by extensive previous studies and meta-analyzes, further confirmation is required.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13225654</identifier><identifier>PMID: 34830807</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Age ; Breast cancer ; Breast feeding ; Breastfeeding &amp; lactation ; Contraception ; Diabetes ; Environmental factors ; Epidemiology ; Family medical history ; Literature reviews ; Menarche ; Meta-analysis ; Mutation ; Obesity ; Oral contraceptives ; Parity ; Post-menopause ; Random variables ; Risk assessment ; Risk factors ; Smoking ; Systematic Review ; Womens health</subject><ispartof>Cancers, 2021-11, Vol.13 (22), p.5654</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023</citedby><cites>FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023</cites><orcidid>0000-0002-9480-926X ; 0000-0002-4864-0184</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2602017712/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2602017712?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74997</link.rule.ids></links><search><creatorcontrib>Barańska, Agnieszka</creatorcontrib><creatorcontrib>Błaszczuk, Agata</creatorcontrib><creatorcontrib>Kanadys, Wiesław</creatorcontrib><creatorcontrib>Malm, Maria</creatorcontrib><creatorcontrib>Drop, Katarzyna</creatorcontrib><creatorcontrib>Polz-Dacewicz, Małgorzata</creatorcontrib><title>Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020</title><title>Cancers</title><description>To perform a meta-analysis of case-control studies that addressed the association between oral contraceptive pills (OC) use and breast cancer (BrCa), PubMED (MEDLINE), Embase, and the Cochrane Library were searched to identify case-control studies of OC and BrCa published between 2009 and 2020. We used the DerSimonian–Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs), and the Mantel–Haenszel test to assess the association between OC use and cancer. Forty-two studies were identified that met the inclusion criteria and we included a total of 110,580 women (30,778 into the BrCa group and 79,802 into the control group, of which 15,722 and 38,334 were using OC, respectively). The conducted meta-analysis showed that the use of OC was associated with a significantly increased risk of BrCa in general, OR = 1.15, 95% CI: 1.01 to 1.31, p = 0.0358. Regarding other risk factors for BrCa, we found that increased risk was associated significantly with early menarche, nulliparous, non-breastfeeding, older age at first parity, postmenopause, obesity, smoking, and family history of BrCa. Despite our conclusion that birth control pills increase the cancer risk being supported by extensive previous studies and meta-analyzes, further confirmation is required.</description><subject>Age</subject><subject>Breast cancer</subject><subject>Breast feeding</subject><subject>Breastfeeding &amp; lactation</subject><subject>Contraception</subject><subject>Diabetes</subject><subject>Environmental factors</subject><subject>Epidemiology</subject><subject>Family medical history</subject><subject>Literature reviews</subject><subject>Menarche</subject><subject>Meta-analysis</subject><subject>Mutation</subject><subject>Obesity</subject><subject>Oral contraceptives</subject><subject>Parity</subject><subject>Post-menopause</subject><subject>Random variables</subject><subject>Risk assessment</subject><subject>Risk factors</subject><subject>Smoking</subject><subject>Systematic Review</subject><subject>Womens health</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtP3DAQx62qVUGUc6-WeuHQFMfO2gmHSsuKPiQQEo-z5Tjj1pDEW4-zaG899Bv0G_aT1LsgBPgy1sxv_vMi5H3JPgnRsENrRgsRS8H5TM6qV2SXM8ULKZvq9ZP_DtlHvGH5CVEqqd6SHVHVgtVM7ZI_59H0dBHGFI2FZfIroNcI1IwdPY5gMNHFtgy98HhL54iAOMCYjuicXq4xwWCSt_QCVh7utmlnkEwxH02_Ro80uCyAUGxLhJ5epqnzgB8pZ6z59_svZ5y9I2-c6RH2H-weuf5ycrX4Vpyef_2-mJ8WVjR1KloQXQduVsqc40DmISrB69o5xoWyHFgDrXHgmlZZ2UrHq5rzLvukmTWZ2SOf73WXUztAZ2Ezda-X0Q8mrnUwXj-PjP6n_hFWupalrKTKAgcPAjH8mgCTHjxa6HszQphQc8kqxutKiox-eIHehCnmrWwpzkqlyk1Hh_eUjQExgntspmR6c2T94sjiP9WHmuQ</recordid><startdate>20211112</startdate><enddate>20211112</enddate><creator>Barańska, Agnieszka</creator><creator>Błaszczuk, Agata</creator><creator>Kanadys, Wiesław</creator><creator>Malm, Maria</creator><creator>Drop, Katarzyna</creator><creator>Polz-Dacewicz, Małgorzata</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9480-926X</orcidid><orcidid>https://orcid.org/0000-0002-4864-0184</orcidid></search><sort><creationdate>20211112</creationdate><title>Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020</title><author>Barańska, Agnieszka ; Błaszczuk, Agata ; Kanadys, Wiesław ; Malm, Maria ; Drop, Katarzyna ; Polz-Dacewicz, Małgorzata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Breast cancer</topic><topic>Breast feeding</topic><topic>Breastfeeding &amp; lactation</topic><topic>Contraception</topic><topic>Diabetes</topic><topic>Environmental factors</topic><topic>Epidemiology</topic><topic>Family medical history</topic><topic>Literature reviews</topic><topic>Menarche</topic><topic>Meta-analysis</topic><topic>Mutation</topic><topic>Obesity</topic><topic>Oral contraceptives</topic><topic>Parity</topic><topic>Post-menopause</topic><topic>Random variables</topic><topic>Risk assessment</topic><topic>Risk factors</topic><topic>Smoking</topic><topic>Systematic Review</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barańska, Agnieszka</creatorcontrib><creatorcontrib>Błaszczuk, Agata</creatorcontrib><creatorcontrib>Kanadys, Wiesław</creatorcontrib><creatorcontrib>Malm, Maria</creatorcontrib><creatorcontrib>Drop, Katarzyna</creatorcontrib><creatorcontrib>Polz-Dacewicz, Małgorzata</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barańska, Agnieszka</au><au>Błaszczuk, Agata</au><au>Kanadys, Wiesław</au><au>Malm, Maria</au><au>Drop, Katarzyna</au><au>Polz-Dacewicz, Małgorzata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020</atitle><jtitle>Cancers</jtitle><date>2021-11-12</date><risdate>2021</risdate><volume>13</volume><issue>22</issue><spage>5654</spage><pages>5654-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>To perform a meta-analysis of case-control studies that addressed the association between oral contraceptive pills (OC) use and breast cancer (BrCa), PubMED (MEDLINE), Embase, and the Cochrane Library were searched to identify case-control studies of OC and BrCa published between 2009 and 2020. We used the DerSimonian–Laird method to compute pooled odds ratios (ORs) and confidence intervals (CIs), and the Mantel–Haenszel test to assess the association between OC use and cancer. Forty-two studies were identified that met the inclusion criteria and we included a total of 110,580 women (30,778 into the BrCa group and 79,802 into the control group, of which 15,722 and 38,334 were using OC, respectively). The conducted meta-analysis showed that the use of OC was associated with a significantly increased risk of BrCa in general, OR = 1.15, 95% CI: 1.01 to 1.31, p = 0.0358. Regarding other risk factors for BrCa, we found that increased risk was associated significantly with early menarche, nulliparous, non-breastfeeding, older age at first parity, postmenopause, obesity, smoking, and family history of BrCa. Despite our conclusion that birth control pills increase the cancer risk being supported by extensive previous studies and meta-analyzes, further confirmation is required.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34830807</pmid><doi>10.3390/cancers13225654</doi><orcidid>https://orcid.org/0000-0002-9480-926X</orcidid><orcidid>https://orcid.org/0000-0002-4864-0184</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-11, Vol.13 (22), p.5654
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8616467
source Publicly Available Content Database; PubMed Central
subjects Age
Breast cancer
Breast feeding
Breastfeeding & lactation
Contraception
Diabetes
Environmental factors
Epidemiology
Family medical history
Literature reviews
Menarche
Meta-analysis
Mutation
Obesity
Oral contraceptives
Parity
Post-menopause
Random variables
Risk assessment
Risk factors
Smoking
Systematic Review
Womens health
title Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A29%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Contraceptive%20Use%20and%20Breast%20Cancer%20Risk%20Assessment:%20A%20Systematic%20Review%20and%20Meta-Analysis%20of%20Case-Control%20Studies,%202009%E2%80%932020&rft.jtitle=Cancers&rft.au=Bara%C5%84ska,%20Agnieszka&rft.date=2021-11-12&rft.volume=13&rft.issue=22&rft.spage=5654&rft.pages=5654-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13225654&rft_dat=%3Cproquest_pubme%3E2604028463%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-be3ddef516020fe648343288ff0237c2e09ebafef9b7c6b6f24822deba6a59023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2602017712&rft_id=info:pmid/34830807&rfr_iscdi=true